Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trial

The clinical and financial implications of a decade of prostate biopsies in the NHS: analysis of Hospital Episode Statistics data 2008-2019

(2020) Ashwin Sunil Tamhankar et al.   BJU INTERNATIONAL

Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis

(2020) Niranjan J. Sathianathen et al.   EUROPEAN UROLOGY

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

(2020) Michael S Hofman et al.   LANCET

Risk of Prostate Cancer after a Negative MRI-Guided Biopsy

(2020) Adam Kinnaird et al.   JOURNAL OF UROLOGY

Transperineal magnetic resonance imaging-targeted biopsy may perform better than transrectal route in the detection of clinically significant prostate cancer? A systematic review and meta-analysis

(2019) Xiang Tu et al.   Clinical Genitourinary Cancer

Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis

(2019) Frank-Jan H. Drost et al.   EUROPEAN UROLOGY

Prospective Validation of Gallium-68 PSMA-PET/CT in Primary Staging of Prostate Cancer Patients

(2019) L.W.M. van Kalmthout et al.   JOURNAL OF UROLOGY

PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA–targeted PET Imaging Studies

(2018) Steven P. Rowe et al.   EUROPEAN UROLOGY

Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What's Next?

(2018) Valeria Panebianco et al.   EUROPEAN UROLOGY

Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI target biopsy

(2018) Sascha Kaufmann et al.   WORLD JOURNAL OF UROLOGY

The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies

(2018) Olivier Wegelin et al.   EUROPEAN UROLOGY

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study

(2018) Marloes van der Leest et al.   EUROPEAN UROLOGY

68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour

(2017) Christian Uprimny et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

(2017) Nicolas Mottet et al.   EUROPEAN UROLOGY

The role of 68Ga-PSMA-I&T PET/CT in the pretreatment staging of primary prostate cancer

(2017) Danielle P. Meyrick et al.   NUCLEAR MEDICINE COMMUNICATIONS

PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2

(2016) Jeffrey C. Weinreb et al.   EUROPEAN UROLOGY

Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR

(2016) Andrew B. Rosenkrantz et al.   JOURNAL OF UROLOGY

Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool

(2015) Gabriele Gaziev et al.   BJU INTERNATIONAL

The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation

(2015) Amanda Nicholson et al.   HEALTH TECHNOLOGY ASSESSMENT

Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies

(2014) Alan W. Partin et al.   JOURNAL OF UROLOGY

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Radical Prostatectomy versus Observation for Localized Prostate Cancer

(2012) Timothy J. Wilt et al.   NEW ENGLAND JOURNAL OF MEDICINE